![Michael Biega](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Biega
Investor Relations Kontakt bei
HARROW, INC.
Profil
Michael Biega is currently VP-Investor Relations & Communications at Harrow, Inc. since 2025.
Formerly, Mr. Biega was Managing Director at Solebury Strategic Communications LLC and Senior Director-Investor Relations at Sensei Biotherapeutics, Inc.
Aktive Positionen von Michael Biega
| Unternehmen | Position | Beginn |
|---|---|---|
| HARROW, INC. | Investor Relations Kontakt | 18.06.2025 |
Ehemalige bekannte Positionen von Michael Biega
| Unternehmen | Position | Ende |
|---|---|---|
Solebury Strategic Communications LLC
 Solebury Strategic Communications LLC Miscellaneous Commercial ServicesCommercial Services Provides investor relations and corporate communications services | Corporate Officer/Principal | - |
| FAETH THERAPEUTICS, INC. | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
2
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Harrow, Inc.
 Harrow, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development, production, and sale of innovative medications | Health Technology |
Solebury Strategic Communications LLC
Solebury Strategic Communications LLC Miscellaneous Commercial ServicesCommercial Services Provides investor relations and corporate communications services | Commercial Services |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
